By combining multimodal clinical and biological data into virtual validation environments, AI is transforming traditional, decade-long drug development cycles, Xu Jie, an associate professor at the Shanghai AI Laboratory, said at the International Biopharma Industry Week Shanghai. AI simulations enable researchers to predict drug efficacy in the human body, significantly accelerating clinical trials and pharmaceutical innovation, she added. #IBIWS2026 #AIforScience